EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 28 (2021) Parasite, 28 (2021) 39 References
Open Access
Review
Issue
Parasite
Volume 28, 2021
Article Number 39
Number of page(s) 11
DOI https://doi.org/10.1051/parasite/2021035
Published online 26 April 2021
  1. Armengol C, Cassaing S, Roques-Malecaze C, Chauvin P, Iriart X, Berry A, Fillaux J. 2017. Time before anti-Toxoplasma IgG seroconversion detection by 7 commercial assays in French pregnant women. Diagnostic Microbiology and Infectious Disease, 87, 103–107. [CrossRef] [PubMed] [Google Scholar]
  2. Begeman IJ, Lykins J, Zhou Y, Lai BS, Levigne P, El Bissati K, Boyer K, Withers S, Clouser F, Noble AG, Rabiah P, Swisher CN, Heydemann PT, Contopoulos-Ioannidis DG, Montoya JG, Maldonado Y, Ramirez R, Press C, Stillwaggon E, Peyron F, McLeod R. 2017. Point-of-care testing for Toxoplasma gondii IgG/IgM using Toxoplasma ICT IgG-IgM test with sera from the United States and implications for developing countries. PLoS Neglected Tropical Diseases, 11, e0005670. [CrossRef] [PubMed] [Google Scholar]
  3. Bongomin F, Govender NP, Chakrabarti A, Robert-Gangneux F, Boulware DR, Zafar A, Oladele RO, Richardson MD, Gangneux J-P, Alastruey-Izquierdo A, Bazira J, Boyles TH, Sarcarlal J, Nacher M, Obayashi T, Worodria W, Pasqualotto AC, Meya DB, Cheng B, Sriruttan C, Muzoora C, Kambugu A, Rodriguez Tudela JL, Jordan A, Chiller TM, Denning DW. 2019. Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts’ consensus recommendations. European Journal of Clinical Microbiology & Infectious Diseases, 38, 1581–1584. [Google Scholar]
  4. Douet T, Armengol C, Charpentier E, Chauvin P, Cassaing S, Iriart X, Berry A, Fillaux J. 2019. Performance of seven commercial automated assays for the detection of low levels of anti-Toxoplasma IgG in French immunocompromised patients. Parasite, 26, 51. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Franck J, Garin YJ-F, Dumon H. 2008. LDBio-Toxo II immunoglobulin G Western blot confirmatory test for anti-toxoplasma antibody detection. Journal of Clinical Microbiology, 46, 2334–2338. [CrossRef] [PubMed] [Google Scholar]
  6. Gajurel K, Dhakal R, Montoya JG. 2015. Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations. Current Opinion in Infectious Diseases, 28, 283–292. [CrossRef] [PubMed] [Google Scholar]
  7. Gay-Andrieu F, Fricker-Hidalgo H, Sickinger E, Espern A, Brenier-Pinchart M-P, Braun H-B, Pelloux H. 2009. Comparative evaluation of the ARCHITECT Toxo IgG, IgM, and IgG Avidity assays for anti-Toxoplasma antibodies detection in pregnant women sera. Diagnostic Microbiology and Infectious Disease, 65, 279–287. [CrossRef] [PubMed] [Google Scholar]
  8. Gomez CA, Budvytyte LN, Press C, Zhou L, McLeod R, Maldonado Y, Montoya JG, Contopoulos-Ioannidis DG. 2018. Evaluation of three point-of-care tests for detection of Toxoplasma immunoglobulin IgG and IgM in the United States: Proof of concept and challenges. Open Forum. Infectious Diseases, 5, ofy215. [Google Scholar]
  9. Guigue N, Menotti J, Hamane S, Derouin F, Garin YJ-F. 2014. Performance of the BioPlex 2200 flow immunoassay in critical cases of serodiagnosis of toxoplasmosis. Clinical and Vaccine Immunology, 21, 496–500. [Google Scholar]
  10. Hofgärtner WT, Swanzy SR, Bacina RM, Condon J, Gupta M, Matlock PE, Bergeron DL, Plorde JJ, Fritsche TR. 1997. Detection of immunoglobulin G (IgG) and IgM antibodies to Toxoplasma gondii: evaluation of four commercial immunoassay systems. Journal of Clinical Microbiology, 35, 3313–3315. [CrossRef] [PubMed] [Google Scholar]
  11. Kasper DC, Prusa AR, Hayde M, Gerstl N, Pollak A, Herkner KR, Reiter-Reisacher R. 2009. Evaluation of the Vitros ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing for acute Toxoplasma gondii infection in pregnant women. Journal of Clinical Microbiology, 47, 164–167. [CrossRef] [PubMed] [Google Scholar]
  12. Levigne P, Peyron F, Wallon M. 2016. Assessment of the diagnostic performance of the IDS-iSYS tests for toxo IgG, toxo IgM and avidity. Diagnostic Microbiology and Infectious Disease, 86, 148–152. [CrossRef] [PubMed] [Google Scholar]
  13. Mahinc C, Flori P, Delaunay E, Guillerme C, Charaoui S, Raberin H, Hafid J, L’Ollivier C. 2017. Evaluation of a new immunochromatography technology test (LDBio Diagnostics) to detect Toxoplasma IgG and IgM: Comparison with the routine Architect technique. Journal of Clinical Microbiology, 55, 3395–3404. [CrossRef] [PubMed] [Google Scholar]
  14. Maudry A, Chene G, Chatelain R, Patural H, Bellete B, Tisseur B, Hafid J, Raberin H, Beretta S, Sung RTM, Belot G, Flori P. 2009. Bicentric evaluation of six anti-Toxoplasma immunoglobulin G (IgG) automated immunoassays and comparison to the Toxo II IgG Western blot. Clinical and Vaccine Immunology, 16, 1322–1326. [CrossRef] [Google Scholar]
  15. Mouri O, Kendjo E, Touafek F, Fekkar A, Konte O, Imbert S, Courtin R, Mazier D, Paris L. 2015. The impact of lowering the cut-off value on the sensitivity of the Platelia Elisa IgG (Bio-Rad) test for toxoplasmosis diagnosis. Parasite, 22, 22. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  16. Murat J-B, Dard C, Fricker Hidalgo H, Dardé M-L, Brenier-Pinchart M-P, Pelloux H. 2013. Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns. Clinical and Vaccine Immunology, 20, 1203–1212. [CrossRef] [Google Scholar]
  17. Petithory JC, Ambroise-Thomas P, De Loye J, Pelloux H, Goullier-Fleuret A, Milgram M, Buffard C, Garin JP. 1996. Le sérodiagnostic de la toxoplasmose: étude comparative multicentrique d’une gamme étalon, par les différents tests actuels et avec expression des résultats en unités internationales. Groupe de travail toxoplasmose du Contrôle national de qualité en parasitologie, Syndicat des fabricants de réactifs de laboratoire, Groupe de travail standardisation des tests sérologiques du Réseau européen de lutte contre la toxoplasmose congénitale. Bulletin of the World Health Organization, 74, 291–298. [PubMed] [Google Scholar]
  18. Prusa A-R, Hayde M, Unterasinger L, Pollak A, Herkner KR, Kasper DC. 2010. Evaluation of the Roche Elecsys Toxo IgG and IgM electrochemiluminescence immunoassay for the detection of gestational Toxoplasma infection. Diagnostic Microbiology and Infectious Disease, 68, 352–357. [CrossRef] [PubMed] [Google Scholar]
  19. Robert-Gangneux F, Bourhis C, Chevrier S, Gangneux J-P. 2009. Evaluation of DPC immulite 2000 Toxoplasma quantitative IgG/IgM kits for automated toxoplasmosis serology with immulite 2000. Journal of Clinical Laboratory Analysis, 23, 336–340. [CrossRef] [PubMed] [Google Scholar]
  20. Robert-Gangneux F, Dardé M-L. 2012. Epidemiology of and diagnostic strategies for toxoplasmosis. Clinical Microbiology Reviews, 25, 264–296. [CrossRef] [PubMed] [Google Scholar]
  21. Robert-Gangneux F, Meroni V, Dupont D, Botterel F, Garcia JMA, Brenier-Pinchart M-P, Accoceberry I, Akan H, Abbate I, Boggian K, Bruschi F, Carratalà J, David M, Drgona L, Djurković-Djaković O, Farinas MC, Genco F, Gkrania-Klotsas E, Groll AH, Guy E, Hirzel C, Khanna N, Kurt Ö, Junie LM, Lazzarotto T, Len O, Mueller NJ, Munoz P, Pana ZD, Roilides E, Stajner T, van Delden C, Villena I, Pelloux H, Manuel O. 2018. Toxoplasmosis in transplant recipients, Europe, 2010–2014. Emerging Infectious Diseases, 24, 1497–1504. [CrossRef] [PubMed] [Google Scholar]
  22. Simon L, Fillaux J, Guigon A, Lavergne R-A, Villard O, Villena I, Marty P, Pomares C, Toxoplasma p35 Study Group. 2020. Serological diagnosis of Toxoplasma gondii: analysis of false-positive IgG results and implications. Parasite, 27, 7. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  23. de Souza GF, Carvalho D, Pedrosa W, Franck J, Piarroux R. 2012. Analytical validation of anti-toxoplasma IgG immunoassays. Brazilian Journal of Infectious Diseases, 16, 574–576. [Google Scholar]
  24. Villard O, Cimon B, L’Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E. 2016. Help in the choice of automated or semiautomated immunoassays for serological diagnosis of toxoplasmosis: Evaluation of nine immunoassays by the French national reference center for toxoplasmosis. Journal of Clinical Microbiology, 54, 3034–3042. [CrossRef] [PubMed] [Google Scholar]
  25. Villard O, Cimon B, L’Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E. 2016. Serological diagnosis of Toxoplasma gondii infection: Recommendations from the French national reference center for toxoplasmosis. Diagnostic Microbiology and Infectious Disease, 84, 22–33. [CrossRef] [PubMed] [Google Scholar]
  26. Villard O, Cimon B, Franck J, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E, Network from the French National Reference Center for Toxoplasmosis. 2012. Evaluation of the usefulness of six commercial agglutination assays for serologic diagnosis of toxoplasmosis. Diagnostic Microbiology and Infectious Disease, 73, 231–235. [CrossRef] [PubMed] [Google Scholar]
  27. Zhang K, Lin G, Han Y, Li J. 2017. The standardization of 5 immunoassays for anti-Toxoplasma immunoglobulin G (IgG). Clinica Chimica Acta, 472, 20–25. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.